Ondine Biomedical Inc. NPV (CDI) (OBI) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 May 2026 09:54 AM
RNS
Notification of major holdings - hInsight-NX, LLC
06 May 2026 09:47 AM
RNS
Notification of major holdings - Carolyn Cross
05 May 2026 05:02 PM
RNS
Notification of major holdings - Pentwater
30 Apr 2026 09:30 AM
RNS
Ondine Presented Steriwave Data at IPC 2026
29 Apr 2026 07:00 AM
RNS
Result of Fundraise & TVR
28 Apr 2026 05:26 PM
RNS
Proposed c.£5 million (C$9.23 million) Fundraise
27 Apr 2026 07:00 AM
RNS
ICU Study to be Presented at 2026 CACCN Conference
23 Apr 2026 07:00 AM
RNS
Marked Reduction in SSIs at Ottawa Heart Institute
22 Apr 2026 07:00 AM
RNS
Two Abstracts Accepted at World Congress
14 Apr 2026 07:00 AM
RNS
Steriwave ICU Study Shows 39.5% Pneumonia Drop
13 Apr 2026 07:00 AM
RNS
Business Update
08 Apr 2026 07:08 AM
RNS
ICU Study Accepted for Publication
24 Mar 2026 04:28 PM
RNS
Holdings in Company
10 Mar 2026 07:00 AM
RNS
Ondine Provides Update on US Phase 3 Pivotal Study
03 Mar 2026 07:00 AM
RNS
Holdings in Company
25 Feb 2026 07:00 AM
RNS
Share Issuance for ICU Study Submission
20 Feb 2026 05:40 PM
RNS
Holding(s) in Company
06 Feb 2026 07:00 AM
RNS
Ondine and Mid Yorks Win National Award
02 Feb 2026 07:00 AM
RNS
Steriwave Up for 2025 “Product of the Year” Award
27 Jan 2026 07:00 AM
RNS
Expanding Steriwave Use Across Vancouver Island
22 Jan 2026 09:42 AM
RNS
Steriwave Expands into ENT Surgery in Spain
13 Jan 2026 07:00 AM
RNS
New Independent Study Supports Photodisinfection
23 Dec 2025 07:00 AM
RNS
Finalist for 2nd National Award for SSI reduction
22 Dec 2025 07:00 AM
RNS
First German Hospital Pilots Steriwave
16 Dec 2025 07:00 AM
RNS
Ondine shortlisted for HSJ Partnership Award
27 Oct 2025 07:00 AM
RNS
Topline Results Significant in Steriwave ICU Study
02 Oct 2025 07:00 AM
RNS
Cambridge’s Papworth Hospital Pilots Steriwave
26 Sep 2025 07:00 AM
RNS
Ondine Biomedical Continues Growth in H1 2025
23 Sep 2025 07:00 AM
RNS
Steriwave Now Protecting Patients with Cancer
19 Sep 2025 07:00 AM
RNS
Notice of Interim Results & Investor Presentation
18 Sep 2025 05:55 PM
RNS
Ondine Presents Major Economic Benefits at ICPIC
15 Sep 2025 10:44 AM
RNS
Steriwave proven to be effective against C Auris
12 Sep 2025 07:00 AM
RNS
Grant of Options
10 Sep 2025 07:00 AM
RNS
Steriwave Featured on CNBC’s Worldwide Exchange
08 Sep 2025 07:00 AM
RNS
Notification of major holdings - hInsight
04 Sep 2025 05:29 PM
RNS
Notification of major holdings - Pentwater
04 Sep 2025 05:27 PM
RNS
Notification of major holdings - Albemarle
04 Sep 2025 05:23 PM
RNS
Notification of major holdings - M&G
04 Sep 2025 05:20 PM
RNS
Notification of major holdings - Robert Cross
04 Sep 2025 05:17 PM
RNS
Notification of major holdings - Carolyn Cross
03 Sep 2025 07:00 AM
RNS
Ondine to present Health Economic Data at ICPIC
01 Sep 2025 07:00 AM
RNS
Total Voting Rights Correction
28 Aug 2025 07:00 AM
RNS
Result of Fundraise & TVR
27 Aug 2025 04:52 PM
RNS
Proposed c.£11m Fundraise
13 Aug 2025 10:52 AM
RNS
First Mexican Hospital Steriwave Deployment
11 Aug 2025 07:00 AM
RNS
Ex-President of Mexico Champions APDT to Cut AMR
22 Jul 2025 05:38 PM
RNS
Share Issuance for ICU Study Enrollment Completion
21 Jul 2025 09:00 AM
RNS
UK Axes Financial support for AMR Fleming Fund
21 Jul 2025 07:00 AM
RNS
Steriwave ICU Study Completes Recruitment
14 Jul 2025 07:00 AM
RNS
Growing Use of Steriwave Across Surgery Types

Ondine Biomedical is a Canadian life sciences company that develops light-activated antimicrobial therapies called photodisinfection to prevent and treat infections, including those from drug-resistant bacteria.

It is listed on LSE under the ticker OBI.

OBI share price launched at 59p in 2021.

UK 100

Latest directors dealings